Vaginal gel for HPV-related cervical changes
Part of Cancer, Infections, Women’s health & pregnancy clinical trials.
This trial tests a vaginal gel that may help restore the health of the cervix in women with HPV. It aims to see if the gel can improve cervical tissue and potentially help clear the infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 30 and 50 years old.
- You have tested positive for HPV.
- Your recent Pap test results show either normal cells or mild changes (not high-grade).
- You are not pregnant, planning to become pregnant, or breastfeeding during the trial.
- You have no immune system disorders and are not taking drugs that weaken the immune system.
- You have not had cervical surgery in the past year or a hysterectomy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a vaginal gel can help early cervical cell changes (CIN1 or CIN2) go away on their own and clear the HPV virus. If you are being monitored without treatment, this gel might increase your chances of recovery.
This study tests a topical gel made from curcumin (a compound in turmeric) to see if it can help clear abnormal cervical cells caused by HPV. It may be an option for women with low-grade changes or who have recently had high-grade changes treated.
This study tests a new vaginal medication (Dysplasix) to treat mild cervical cell changes caused by high-risk HPV. The goal is to see if this treatment can help your body clear the virus and prevent these changes from getting worse.
This trial tests whether Papillex, a supplement, can help clear abnormal cervical cells caused by HPV. You may be eligible if you have HPV and abnormal cell changes that haven't been treated recently.
This trial tests whether a vaccine against HPV can help prevent pre-cancerous lesions from coming back after you've had them. It's for people who have had high-grade pre-cancerous lesions but haven't yet been treated for them.
This trial studies 2LPAPI® to see if it helps the body clear high-risk HPV infections in the cervix. It may be an option if you have a current HPV infection with mild/early abnormal cervical findings and can complete follow-up for about a year.
Hear when a new Human Papillomavirus Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.